News & Updates

Two of the biggest obstacles to surviving cancer after surgery to remove the primary tumor are that the tumors tend to come back, and worse, they spawn distant metastases that are difficult to treat. Scientists at Dana-Farber Cancer Institute and Harvard have invented an immunotherapy “gel” that can be placed at the tumor site during … Read more

Researchers at the Dana-Farber Cancer Institute have found that in mice, implanting a small disc of gel during surgery that slowly releases an immune-boosting drug afterward appears to help keep the cancer from recurring. The researchers tested more than a hundred mice with breast cancer, lung cancer or melanoma. After their tumors were removed, the … Read more

A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal of a tumor. In the study, published online today by Science Translational Medicine, researchers removed breast tumors from mice and placed biodegradable gels containing … Read more

PRINCETON, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, today announced that Carmine Therapeutics and STIMIT are the winners of Bristol-Myers Squibb’s 2019 Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two … Read more